Roche COBAS INTEGRA 400 Analyzer Recalled for Software Security Issue
Roche is recalling COBAS INTEGRA 400 analyzers due to a security vulnerability in the Oracle TNS-Listener component that could allow unauthorized database access.
The agency’s classification
FDA (Devices): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard is a software security vulnerability rather than a direct physical or biological health risk, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Roche Diagnostics Operations, Inc. is recalling 845 units of the Roche COBAS INTEGRA 400 and 400 plus Analyzer. These are in vitro diagnostic analyzers distributed nationwide, including in 41 states, the District of Columbia, and Guaynabo, Puerto Rico.
The recall is due to a software security issue identified in the Oracle TNS-Listener component supplied with the analyzers. TNS-Listener functions as an authentication and redirection component between the client and the internal database. The vulnerability means an attacker could potentially register their own non-Roche database via remote access.
Healthcare facilities and users of these analyzers should contact Roche Diagnostics Operations, Inc. for instructions on how to address the security issue. The affected units are identified by Part Numbers 28065047001 and 03245233001.
The recalled product
- Product
- Roche COBAS INTEGRA 400 and 400 plus Analyzer, an in vitro diagnostic analyzer.
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Hazard
- Affected units
- 845
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part Numbers: 28065047001 and 03245233001
Distribution
Related recalls
Same manufacturer · Roche Diagnostics Operations, Inc.
See all →- HighRoche cobas analyzer may repeat previous results for spline calibrated assays
FDA (Devices) · 2026-03-11
- HighThyroid receptor immunoassay recalled over variable results across instrument platforms
FDA (Devices) · 2026-01-14
- HighMedical Device Homocysteine Test Assay Recalled for Calibration Defects
FDA (Devices) · 2024-11-27
- HighRoche Creatine Kinase test reagents recalled for calibration errors
FDA (Devices) · 2024-10-02
- HighRoche Tina-quant D-Dimer Test System Recalled for Inaccurate Results
FDA (Devices) · 2023-11-29
Same hazard · software security
See all →- HighRadiometer ABL90 FLEX Analyzer Recalled for Software Security Vulnerabilities
FDA (Devices) · 2019-08-28
Similar recalls
- ModerateRoche Recalls COBAS INTEGRA 400 Analyzer Software Due to Diagnostic Issue
FDA (Devices) · 2012-12-19
- HighRoche COBAS INTEGRA c111 Analyzer Recall for Software Error
FDA (Devices) · 2016-11-16
- HighRoche COBAS INTEGRA 800 Analyzer Recalled for Software Maintenance Defect
FDA (Devices) · 2013-11-13
- ModerateRoche COBAS INTEGRA 400 plus Recall for Carry-over Issues
FDA (Devices) · 2019-04-17
- SevereRoche COBAS INTEGRA 800 Analyzer Recalled Due to Sharp Edge Injury Reports
FDA (Devices) · 2016-11-02
- ModerateRoche COBAS 8000 Analyzer Software Recall for Diagnostic Issue
FDA (Devices) · 2012-12-19